Globus Medical, Inc. (GMED)
76.71
-2.13
(-2.70%)
USD |
NYSE |
Oct 16, 16:00
76.63
-0.08
(-0.10%)
Pre-Market: 20:00
Globus Medical Research and Development Expense (Annual) : 146.94M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 146.94M |
| December 31, 2024 | 151.14M |
| December 31, 2023 | 124.01M |
| December 31, 2022 | 72.86M |
| December 31, 2021 | 63.03M |
| December 31, 2020 | 60.10M |
| December 31, 2019 | 60.07M |
| December 31, 2018 | 55.50M |
| December 31, 2017 | 43.68M |
| Date | Value |
|---|---|
| December 31, 2016 | 44.53M |
| December 31, 2015 | 36.98M |
| December 31, 2014 | 31.69M |
| December 31, 2013 | 26.87M |
| December 31, 2012 | 27.93M |
| December 31, 2011 | 23.46M |
| December 31, 2010 | 21.31M |
| December 31, 2009 | 20.52M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.889B |
| Merit Medical Systems, Inc. | 97.35M |
| Teleflex, Inc. | 144.78M |
| The Cooper Cos., Inc. | 172.20M |
| Intuitive Surgical, Inc. | 1.312B |